IPCA Laboratories has reportedly got US Food and Drug Administration (USFDA) import alert for Ratlam plant in Madhya Pradesh due to violations of standard production practices.
FDA had issued Form 483 to Ratlam API in mid 2014. In form 483s, FDA pointed out data integrity issues at Ratlam plant. Ratlam is the only USFDA approved API plant and thus US revenues will get impacted following the alert.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1846.50 |
| Dr. Reddys Lab | 1305.30 |
| Cipla | 1363.20 |
| Zydus Lifesciences | 930.95 |
| Lupin | 2425.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: